| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.15 Billion | USD 9.66 Billion | 6.50% | 2024 |
FrequentlyAsked Questions
Gastroenterology products encompass a broad range of medical devices, pharmaceuticals, and instruments specifically designed for the treatment, diagnosis, and management of digestive system diseases. These products encompass areas such as capsule endoscopes, endoscopy equipment, stents, biopsy devices, and medications for conditions like ulcers, acid reflux, irritable bowel syndrome, and Crohn's disease.
The global gastroenterology products market is projected to grow due to the rising prevalence of gastrointestinal disorders, the increasing adoption of minimally invasive procedures, and rising global healthcare expenditure.
According to study, the global gastroenterology products market size was worth around USD 5.15 billion in 2024 and is predicted to grow to around USD 9.66 billion by 2034.
The CAGR value of the gastroenterology products market is expected to be approximately 6.50% during the period 2025-2034.
Emerging trends include minimally invasive procedures, AI-assisted diagnostics, biologics and targeted therapies, capsule endoscopy, and digital health integration.
Key opportunities include the adoption of minimally invasive procedures, the rising prevalence of GI disorders, the expansion in emerging markets, AI and digital health integration, and the development of biologics and targeted therapies.
North America is expected to lead the global gastroenterology products market during the forecast period.
The key players profiled in the global gastroenterology products market include Olympus Corporation, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson (Ethicon), FUJIFILM Holdings Corporation, CONMED Corporation, Stryker Corporation, Pentax Medical (HOYA Group), B. Braun Melsungen AG, Cardinal Health, Inc., Smith & Nephew plc, KARL STORZ SE & Co. KG, Alvimedica, EndoChoice Holdings, Inc., and ERBE Elektromedizin GmbH.
The competitive landscape is highly fragmented, dominated by strategic partnerships, global players investing in R&D, and mergers & acquisitions to expand product portfolios, drive innovation in devices, diagnostics, and pharmaceuticals, and enter new markets.
The report examines key aspects of the gastroenterology products market, including a detailed analysis of existing growth factors and restraints, as well as an examination of future growth opportunities and challenges that will impact the market.
HappyClients